Charles L Shapiro, MD
-
- Position
- PROFESSOR | Medicine, Hematology and Medical Oncology
-
- Language
- English
-
- Hospital Affiliation
- The Mount Sinai Hospital
Dr. Shapiro is Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. He is the Director of the Translational Breast Cancer Research for the Mount Sinai Health System and Director of Survivorship Programs at The Tisch Cancer Institute. Dr. Shapiro sees patients at the Dubin Breast Center of The Tisch Cancer Institute.
Dr. Shapiro’s clinical research interests include bone health, specifically the impact of adjuvant chemotherapy on bone loss in premenopausal women; development of new, effective treatments; and clinical trials that feature novel therapies. Dr. Shapiro is committed to providing the best treatments tailored to each patient for optimal outcomes and empowering women to regain control over their lives.
Professor of Medicine
Director of Translational Breast Cancer Research
Director of Cancer Survivorship, Tisch Cancer Institute
Division of Hematology/Medical Oncology Department of Medicine
Clinical Focus
Language
English
2013
Physicians recognized for being in the top 10 percent for patient satisfaction, nationally
2005
America's Top Doctors for Cancer
2005
Bertha Bouroncle Teaching Award
2001
America's Top Doctors
1998
Best Doctors in America
1991
American Cancer Society Clinical Oncology Career Development
American Cancer Society
The James Champion Award
James Cancer Hospital
Bacilli Award for Academic Excellence
University of Buffalo Medical School
John Watson Award for Scholarship in Medicine
University of Buffalo Medical School
Alpha Omega Alpha
New topic
The focus of my research is investigator-initiated early phase clinical trials in breast cancer. Areas of interest include: breast cancer survivorship, in particular the impact and treatment of adjuvant chemotherapy-induced bone loss in premenopausal women; microRNA profiling of triple negative breast cancers to define subsets that have better or worse prognosis; and preclinical evaluations of novel drugs in collaboration with a medicinal chemist, including a PDK-1 inhibitor, AMP kinase inhibitor and the PARP inhibitors. At Mount Sinai I plan to form collaborations with laboratory-based scientists to evaluate novel drugs preclinically, develop investigator-initiated trials to further define subsets of triple negative breast cancers using genomic methods, and to conduct investigator-initiated trials in breast cancer survivorship.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Shapiro during 2021 and/or 2022. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Anthemum
- Cardinal Health
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Up to Date
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.